NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.5 million versus the consensus estimate of $61.83 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.